Cardiovascular effects of fingolimod: A review article

Multiple sclerosis (MS) is a chronic auto-immune disease. Most therapeutic strategies for treatment of this disease direct immune modulation and control of inflammatory processes. First-line therapeutic agents showed moderate efficacy and frequent side-effects with moderate efficacy in trials. Their...

Descripción completa

Detalles Bibliográficos
Autores principales: Behjati, Mohaddeseh, Etemadifar, Masoud, Abdar Esfahani, Morteza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Neurological Association 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240927/
https://www.ncbi.nlm.nih.gov/pubmed/25422729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240927/
https://www.ncbi.nlm.nih.gov/pubmed/25422729

Ejemplares similares